Table 6 Community state type distribution in pregnant and non-pregnant (menarcheal) cohorts by trial arm, iron deficiency and infection status

Trial arm

ANC1

Iron

144

70 (48.6)

39 (27.1)

35 (24.3)

0.518

Control

136

61 (44.9)

45 (33.1)

30 (22.1)

FIN^b

Iron

349

121 (34.7)

88 (25.2)

140 (40.1)

0.113

Control

341

140 (1.1)

66 (19.4)

135 (9.6)

Iron deficiency, Adjusted ferritin

ANC1

No

249

118 (47.4)

75 (30.1)

56 (22.5)

0.57

Yes

27

10 (37.0)

9 (33.3)

8 (29.6)

FIN^b

No

620

237 (38.2)

140 (22.6)

243 (39.2)

0.281

Yes

65

20 (30.8)

13 (20.0)

32 (49.2)

Ratio sTfR/log ferritin

ANC1

No

247

120 (48.6)

74 (30.0)

53 (21.5)

0.216

Yes

32

11 (34.4)

10 (31.2)

11 (34.4)

FIN^b

No

544

205 (37.7)

124 (22.8)

215 (39.5)

0.81

Yes

140

52 (37.1)

29 (20.7)

59 (42.1)

Nugent score^c

ANC1

7-10

15

0 (0)

1 (6.7)

14 (93.3)

<0.001

4-6

31

7 (22.6)

6 (19.4)

18 (58.1)

<0.001

0-3

221

116 (52.5)

74 (33.5)

31 (14.0)

<0.001

FIN^b

7-10

80

2 (2.5)

6 (7.5)

72 (90.0)

<0.001

4-6

60

11 (18.3)

6 (10.0)

43 (71.7)

<0.001

0-3

501

232 (46.3)

132 (26.3)

137 (27.3)

<0.001

T. vaginalis

ANC1

No

243

121 (49.8)

73 (30.0)

49 (20.2)

0.006

Yes

37

10 (27.0)

11 (29.7)

16 (43.2)

FIN^b

No

655

260 (39.7)

149 (22.7)

246 (37.6)

<0.001

Yes

35

1 (2.9)

5 (14.3)

29 (82.9)

High pH ≥ 4.5

ANC1

No

123

73 (59.3)

37 (30.1)

13 (10.6)

<0.001

Yes

153

58 (37.9)

45 (29.4)

50 (32.7)

Vaginal discharge

ANC1

No

260

122 (46.9)

80 (30.8)

58 (22.3)

0.268

Yes

20

9 (4.5)

4 (20.0)

7 (35.0)

FIN^b

No

618

232 (37.5)

144 (23.3)

242 (39.2)

0.205

Yes

69

28 (40.6)

10 (14.5)

31 (44.9)

Antibiotics within previous three months

ANC1

No

252

118 (46.8)

73 (29.0)

61 (24.2)

NA

Yes

28

13 (46.4)

11 (39.3)

4 (14.3)

FIN^b

No

616

236 (38.3)

136 (22.1)

244 (39.6)

NA

Yes

74

25 (33.8)

18 (24.3)

31 (41.9)